Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Androgen Deprivation + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 2
Tampa, Florida
This trial aims to see if using a combination of adaptive androgen deprivation therapy (ADT) and Docetaxel can help in extending the period of time before prostate cancer becomes resistant to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.